BACKGROUND Familial Mediterranean fever (FMF) is an autoinflammatory syndrome characterized by recurrent episodes of fever and aseptic polyserositis. Subclinical inflammation generates a hidden threat to the development of FMF complications… Click to show full abstract
BACKGROUND Familial Mediterranean fever (FMF) is an autoinflammatory syndrome characterized by recurrent episodes of fever and aseptic polyserositis. Subclinical inflammation generates a hidden threat to the development of FMF complications such as amyloidosis in attack-free intervals. The kynurenine pathway (KP) has been considered an important player in inflammation and immune response. The study was aimed to measure serum levels of KP metabolites in patients with FMF in the attack-free period. METHODS A total of 161 participants were recruited from the rheumatology department in this single-center, case-control study. Participants meeting the eligibility criteria were divided into healthy controls (n=80) and FMF (n=81). The laboratory data were obtained from the electronic registration database. Serum tryptophan, kynurenine, kynurenic acid, 3-hydroxyanthranilic acid, 3-hydroxykynurenine, quinolinic acid concentrations were measured with tandem mass spectrometry. Laboratory findings of FMF patients and healthy controls subjects were compared and evaluated. RESULTS Serum tryptophan, kynurenic acid levels were significantly decreased in both FMF groups compared to the control group, while the levels of kynurenine, quinolinic acid, 3-hydroxykynurenine, the Kynurenine/Tryptophan ratio, and RDW were higher. CONCLUSION Tryptophan degradation by the KP is increased in patients with FMF. KP metabolites can be useful in demonstrating subclinical inflammation.
               
Click one of the above tabs to view related content.